DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS

被引：0
|
作者：
Oldgren, Jonas
Alings, Marco
Darius, Harald
Eikelboom, John
Ezekowitz, Michael
Parekh, Amit
Pogue, Janice
Reilly, Paul
Yusuf, Salim
Wallentin, Lars
Connolly, Stuart
机构：
[1] Uppsala Clin Res Ctr, Uppsala, Sweden
[2] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0903-04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dabigatran better than warfarin in patients with atrial fibrillation and stroke risk - RE-LY study.
    Gadomska, Lucja
    KARDIOLOGIA POLSKA, 2009, 67 (10) : 1151 - 1152
  • [22] A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS2 score in Japan
    Kimura, Takehiro
    Igarashi, Ataru
    Ikeda, Shunya
    Nakajima, Kazuaki
    Kashimura, Shin
    Kunitomi, Akira
    Katsumata, Yoshinori
    Nishiyama, Takahiko
    Nishiyama, Nobuhiro
    Fukumoto, Kotaro
    Tanimoto, Yoko
    Aizawa, Yoshiyasu
    Fukuda, Keiichi
    Takatsuki, Seiji
    JOURNAL OF CARDIOLOGY, 2017, 69 (1-2) : 89 - 97
  • [23] The efficacy and safety of low intensity warfarin therapy in Chinese elderly atrial fibrillation patients with high CHADS2 risk score
    Wu, Jun
    Wang, Junhong
    Jiang, Surong
    Xu, Jian
    Di, Qun
    Zhou, Chuanwei
    Min, Xiaoyan
    Pang, Sisi
    Wang, Hui
    Xu, Di
    Guo, Yan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 3067 - 3068
  • [24] Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation - a RE-LY Trial Analysis
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Siegbahn, Agneta
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION, 2013, 128 (22)
  • [25] Anticoagulation for Atrial Fibrillation Patients with CHADS2 Score of 1
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (05) : 508 - 510
  • [26] COMPARATIVE EFFICACY AND SAFETY ANALYSIS OF ATRIAL FIBRILLAION PATIENTS TREATED WITH DABIGATRAN IN RE-LY STUDY (CHADS 2 SCORE OF 3 OR GREATER) VERSUS RIVAROXABAN IN ROCKET-AF
    Rasty, S.
    Soliman, W.
    Taheri, R.
    VALUE IN HEALTH, 2012, 15 (07) : A362 - A362
  • [27] Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial (vol 9, pg 1157, 2010)
    Diener, H. C.
    Connolly, S. J.
    Ezekowitz, M. D.
    LANCET NEUROLOGY, 2011, 10 (01): : 27 - 27
  • [28] Stroke and CHADS2 Score Do Not Predict Warfarin Use Nationally in Atrial Fibrillation
    Barnes, Geoffery D.
    Chae, Sanders
    Froehlich, James B.
    CIRCULATION, 2010, 122 (21)
  • [29] Risk of bleeding in very old Atrial Fibrillation patients on warfarin: relationship with ageing and CHADS2 score
    Poli, D.
    Antonucci, E.
    Marcucci, R.
    Falciani, M.
    Ciuti, G.
    Abbate, R.
    Gensini, G. F.
    Prisco, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 37 - 37
  • [30] Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial
    Hori, Masatsugu
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION JOURNAL, 2011, 75 (04) : 800 - 805
12345